Samir Drugs Private Limited

Wholesale trading of yarn, fabrics, medicines, drugs, and medical products.

2003 | Mumbai, Maharashtra (India) | Inactive
Last Updated: April 24, 2024

Samir Drugs Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 2 Months
  • Last Filing with ROC 31 Mar 2016
  • Revenue Growth -35.41%
  • Profit Growth 73.64%
  • Ebitda 73.64%
  • Net Worth 13.10%
  • Total Assets -45.55%

About Samir Drugs

Samir Drugs Private Limited (SDPL) is Strike Off company established on 02 Dec 2003 with its office registered at Mumbai, Maharashtra, India and has been running since 21 Year, 2 Months with a paid up capital of 0.10 M. According to MCA records, 3 Directors are linked to this company as of 24 Apr 2024.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230MH2003PTC143338

  • Company No.

    143338

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    02 Dec 2003

  • Date of AGM

    26 Sep 2016

  • Date of Balance Sheet

    31 Mar 2016

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Home & Lifestyle
Pharma

Who are the key members and board of directors at Samir Drugs?

Board Members (3)

Name Designation Appointment Date Status
Afzal Mansuri Country flag representing In Director 01-Mar-2016 Current
Vaishali Shah Country flag representing In Director 06-Nov-2017 Current
Bhavesh Shah Country flag representing In Director 30-Mar-2007 Current

Financial Performance of Samir Drugs.

Samir Drugs Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 35.41% decrease. The company also saw a substantial improvement in profitability, with a 73.64% increase in profit. The company's net worth Soared by an impressive increase of 13.1%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
-35.41%
Revenue from Operations
-35.41%
Total Assets
-45.55%
Profit or Loss
73.64%
Net Worth
13.10%
EBITDA
73.64%

What is the Ownership and Shareholding Structure of Samir Drugs?

In 2016, Samir Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Samir Drugs?

Unlock and access historical data on people associated with Samir Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Samir Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samir Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Samir Drugs

Recent activity within the organization

  • Director Appointment

    Vaishali Bhavesh Shah was appointed as a Director was appointed as a Director on 06 Nov 2017 & has been associated with this company since 7 years 2 months .

    06 Nov 2017

  • Annual General Meeting

    Samir Drugs Private Limited last Annual general meeting of members was held on 26 Sep 2016 as per latest MCA records.

    26 Sep 2016

  • Balance Sheet

    Samir Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai.

    31 Mar 2016

  • Director Appointment

    Afzal Mohammed Mansuri was appointed as a Director was appointed as a Director on 01 Mar 2016 & has been associated with this company since 8 years 11 months .

    01 Mar 2016

  • Director Appointment

    Bhavesh Himatlal Shah was appointed as a Director was appointed as a Director on 30 Mar 2007 & has been associated with this company since 17 years 10 months .

    30 Mar 2007

  • Company Incorporation

    Samir Drugs Private Limited was registered on 02 Dec 2003 with Roc Mumbai & aged 21 years 2 months as per MCA records.

    02 Dec 2003

Frequently asked questions

  • Samir Drugs Private Limited was incorporated on 02 Dec 2003.

  • The authorized share capital of Samir Drugs Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Samir Drugs Private Limited.

    • Afzal Mohammed Mansuri
    • Vaishali Bhavesh Shah
    • Bhavesh Himatlal Shah
  • As per Ministry of Corporate Affairs (Mca), the registered address of Samir Drugs Private Limited is Shop No G/67 Om Heera Panna Premises Chsl, Behind Oshiwara Police Station Andheri (West), Mumbai, Maharashtra, India, 400053.

  • The corporate identification number (CIN) of Samir Drugs Private Limited is U24230MH2003PTC143338 and the company number is 143338 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2016, the revenue trend for Samir Drugs Private Limited has fallen by -35.41%.

  • The financial reports for the fiscal year 2016 indicates that The net worth of Samir Drugs Private Limited has experienced an upsurge of 13.10%.

  • The most recent Balance Sheet for Samir Drugs Private Limited was filed with the ROC on 31 Mar 2016.

People also Viewed

Similar Companies Based on Drug Formulation & Development